INEX Innovate commended by global business consulting firm Frost & Sullivan with their Singapore Women’s Health Entrepreneurial Company of the Year Award.

     Based on Frost & Sullivan’s research and analysis of the 2021 life sciences industry, Frost & Sullivan presents INEX Innovate with the 2021 Singapore Women’s Health Entrepreneurial Company of The Year (Clinical Laboratories) award for Excellence in Best Practices.

    From left to right: Dr. Chia-Pin Chang – Vice President of Research & Development, Kane Black – Chief Executive, Dr. Sherry Ho – Laboratory Director

    Subscribe to our Telegram channel to get a daily dose of business and lifestyle news from NHA – News Hub Asia!

    Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as customer service, leadership, technological innovation, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

    INEX Innovate is wellrecognised within the maternal-fetal medicine and obstetrics and gynaecology community as a solutions provider for women’s health. Over the years, INEX has continued to work in tandem with global centres of research excellence, internationally renowned molecular diagnostic companies and healthcare providers to better improve the testing landscape for women. INEX’s versatility was also exhibited when it made the pivot towards COVID-19 testing, in an effort to contribute towards the testing capacity in Singapore.

    Dr. Milind Sabnis, Director of Healthcare at Frost & Sullivan said “In a position to offer much-needed precision healthcare solutions for women, INEX Innovate delivers industry-leading technological advancements founded on its expertise in identifying and addressing clinically unmet needs within the feto-maternal and oncology landscape. The company’s support in battling the COVID-19 pandemic in Singapore highlights its unique value and passion for improving the population’s health. This vertically integrated company owns the internationally recognised iGene Laboratory, which offers a range of unique and clinically valuable molecular diagnostic testing services. As such, INEX has registered an overall solid performance in 2020.”

    “On behalf of the entire team at INEX Innovate and iGene Laboratory, we are delighted to have been recognised by global industry expert Frost & Sullivan for our entrepreneurial spirit with the award of Singapore Women’s Health Entrepreneurial Company of The Year,” said INEX CEO Kane Black. “As a young company, we have come a long way within a short span none of which would have been possible without the great team work, dedication, commitment and support of the entire INEX team. I am very proud to have a team consisting of some of the most talented in the sector.

    Source: INEX Innovate